Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2401-2026

Bicarby Dialysate; Recall

Bicarby Dialysate; Model number: RFP-400-G;

FDA recall Class II

Ongoing

FDA lists this Class II recall for Bicarby Dialysate;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2401-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 7, 2026
FDA report date
Jun 17, 2026
Quantity in commerce
4752
Distribution
See key details
FDA cause
Process control

What is being recalled?

Bicarby Dialysate; Model number: RFP-400-G;

Affected model & UDI checker

Search the exact identifiers published for Z-2401-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
RFP-400-GBicarby Dialysate;Check source noticeNot specified
Not specifiedBicarby Dialysate;Check source notice00840861102839
FDA code information

Model number: RFP-400-G; UDI-DI: 00840861102839; Lot codes: 25SG06026, 25SG06027;

View the original FDA recall notice

Why was this product recalled?

There is an error in the labeling of the GTIN on the product. When scanned; however, the case labeling, lot number, and printed labeling on the product correctly identifies the product code and the solution contained in the bag. In the event the incorrect GTIN labeling is used as the singular source for product identification, unrecognized use of a potassium solution with a concentration differing from the prescription may result.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Fresenius Medical Care Holdings, Inc. take?

On 5/7/2026 an URGENT MEDICAL DEVICE RECALL letters were sent to customers. At this time, FMCRTG is providing this recall notice to alert you of the potential risks associated with the labeling error, and to ask that you identify, segregate, and discontinue use of affected lots, 25SG06026 and 25SG06027, of RFP-400-G Bicarby Dialysate. FMCRTG is requiring the return of the affected Bicarby Dialysate lots. FMCRTG will replace all remaining stock of affected product lots. For product technical questions or concerns, please contact Technical Support at 1-800-323-2732 or Customer Support at 1-800-323-5188 between 8:30AM 4:30PM Eastern Daylight Time. For any clinical or medical questions, please contact the Global Medical Information and Education Office at 1-855-616-2309.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology